Smart Pill Market Comprehensive Study 2018: Medtronic , Otsuka Holdings Company Limited., Olympus Corporation, CapsoVision Inc. , Check-Cap , IntroMedic , JINSHAN Science & Technology and Lucid Group Limited

Global Smart Pill Market, By Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring of Cancer), By Disease Indication (Occult GI Bleeding, Crohn’s Disease, Small Bowel Tumors, Celiac Disease, Inherited Polyposis Syndromes, Mental Disorders), By Type (Multiparameter Monitoring, Single Parameter Monitoring), By End User (Hospital, Diagnostic Centers, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2025

Major Players: Global Smart Pills Market

Some of the major players operating in this market are

• Medtronic ,
• Otsuka Holdings Company Limited.,
• Olympus Corporation,
• CapsoVision Inc.,
• Check-Cap ,
• IntroMedic ,
• JINSHAN Science & Technology and
• Lucid Group Limited
• among others.

Download Free Sample PDF Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-smart-pills-market

Global Smart Pills Market highly concentrated to a few big players and rest to local players who cater to domestic markets only. Smart pills market is dominated by Medtronic, accounting for a highest market share in 2017, followed by Otsuka Holdings Company Limited and Olympus Corporation, among others.

TECHNOLOGICAL ADVANCEMENTS AND R&D INVESTMENT IN SMART PILLS MARKET

The healthcare sector is focusing on smart pill technology also known as ingestible other than wearables and embeddable medicines. For instance, Proteus Digital Health (U.S.), which is a manufacturer of digital medicine, has developed a system consisting of a smartphone, a sensor patch and a pill. These pill consist of one-square-millimeter sensor coated with two digestible metals copper and magnesium. The metals used in the chip consist of multi-vitamin supplements and are not hazardous to health. After swallowing the pill, the sensor gets activated by interaction of electrolytes within the body. After the activation pill transmits signals to the battery-powered patch worn on the patient’s torso and sends the data via Bluetooth to a doctors or to any family member’s smartphone.

INCREASING PREVALENCE OF GASTROINTESTINAL DISORDERS

The gastrointestinal disease accounts for a large number of deaths around the world. The incidences of the colorectal cancer (CRC), which is also known as bowel cancer or colon cancer is increasing day by day among people globally. The CRC affects the colon and the rectum in the human body. There are also some diseases and infections in the gastrointestinal tract, related to the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion such as gastroesophageal reflux disease, Gallstones, Celiac Disease, Crohn’s Disease, Ulcerative Colitis and others that are becoming a great problem for the people

According to an article published by the BioMedPress, in 2016, around many new cases and many deaths were observed worldwide due to colorectal cancer. In 2012, around 693,099 CRC deaths have been recorded worldwide, which accounted for 8.0% of all cancer deaths.

According to an article published by Gastrointestinal Society, In 2008 inflammatory bowel diseases (IBD) which include ulcerative colitis and Crohn’s disease have been primarily observed in developed countries. Treatment for both forms of IBD includes drug therapy, supplemental nutrition or surgery.

For More Inquiry Contact us at https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-smart-pills-market

TABLE OF CONTENTS GLOBAL SMART PILLS MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL SMART PILLS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 SECONDARY SOURCES
2.8 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 INCREASING PREVALENCE OF GASTROINTESTINAL DISORDERS
5.1.2 RISING CANCER SCREENING AWARENESS PROGRAMS
5.1.3 TECHNOLOGICAL ADVANCEMENTS AND R&D INVESTMENT IN SMART PILLS MARKET
5.1.4 FAVOURABLE REIMBURSEMENT POLICIES FOR CAPSULE ENDOSCOPY
5.1.5 RISING NEED OF MINIMALLY INVASIVE SURGERIES

5.2 RESTRAINTS

5.2.1 HIGH COSTS OF SMART PILLS
5.2.2 ETHICAL CONCERNS RELATED TO SMART PILLS FOR DRUG DELIVERY

5.3 OPPORTUNITIES

5.3.1 NEED FOR RAPID DRUG DEVELOPMENT PROCESS
5.3.2 RISING NEED FOR THE FOCUS AND MOTIVATION IN DAILY LIFE FOR PEOPLE

5.4 CHALLENGES

5.4.1 LACK OF TRAINED STAFF
5.4.2 POSSIBLE HEALTH RISK ASSOCIATED WITH A SMART PILL INSERTED INTO A BODY

6 GLOBAL SMART PILLS MARKET, BY APPLICATION

6.1 OVERVIEW

6.2 CAPSULE ENDOSCOPY

6.2.1 SMALL BOWEL CAPSULE ENDOSCOPY
6.2.2 COLON CAPSULE ENDOSCOPY

6.3 DRUG DELIVERY

6.4 PATIENT MONITORING OF CANCER

7 GLOBAL SMART PILLS MARKET, BY DISEASE INDICATION

7.1 OVERVIEW
7.2 OCCULT GI BLEEDING
7.3 CROHN’S DISEASE
7.4 SMALL BOWEL TUMORS
7.5 CELIAC DISEASE
7.6 INHERITED POLYPOSIS SYNDROMES
7.7 MENTAL DISORDERS

8 GLOBAL SMART PILLS MARKET, BY TYPE

8.1 OVERVIEW
8.2 MULTIPARAMETER MONITORING
8.3 SINGLE PARAMETER MONITORING

9 GLOBAL SMART PILLS MARKET, BY END USER

9.1 OVERVIEW
9.2 HOSPITAL
9.3 DIAGNOSTIC CENTERS
9.4 OTHERS

10 GLOBAL SMART PILLS MARKET, BY GEOGRAPHY

10.1 GLOBAL

10.2 NORTH AMERICA

10.2.1 U.S.
10.2.2 CANADA
10.2.3 MEXICO

10.3 EUROPE

10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 U.K.
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 SWITZERLAND
10.3.7 NETHERLANDS
10.3.8 RUSSIA
10.3.9 BELGIUM
10.3.10 TURKEY
10.3.11 REST OF EUROPE

10.4 ASIA PACIFIC

10.4.1 CHINA
10.4.2 JAPAN
10.4.3 INDIA
10.4.4 SOUTH KOREA
10.4.5 AUSTRALIA
10.4.6 SINGAPORE
10.4.7 THAILAND
10.4.8 MALAYSIA
10.4.9 INDONESIA
10.4.10 PHILIPPINES
10.4.11 REST OF ASIA PACIFIC

10.5 SOUTH AMERICA

10.5.1 BRAZIL

10.5.2 REST OF SOUTH AMERICA

10.6 MIDDLE EAST AND AFRICA

10.6.1 SOUTH AFRICA
10.6.2 REST OF MIDDLE EAST & AFRICA

11 GLOBAL SMART PILLS MARKET, COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: GLOBAL
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3 COMPANY SHARE ANALYSIS: EUROPE
11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12 COMPANY PROFILE

12.1 MEDTRONIC

12.1.1 COMPANY OVERVIEW
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS

12.2 OTSUKA HOLDINGS COMPANY LIMITED

12.2.1 COMPANY OVERVIEW
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS

12.3 OLYMPUS CORPORATION

12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS

12.4 CAPSOVISION, INC.

12.4.1 COMPANY OVERVIEW
12.4.2 PRODUCT PORTFOLIO
12.4.3 RECENT DEVELOPMENTS

12.5 CHECK CAP

12.5.1 COMPANY OVERVIEW
12.5.2 GEOGRAPHIC PRESENCE
12.5.3 PRODUCT PORTFOLIO
12.5.4 RECENT DEVELOPMENTS

12.6 INTROMEDIC

12.6.1 COMPANY OVERVIEW
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS

12.7 JINSHAN SCIENCE & TECHNOLOGY

12.7.1 COMPANY OVERVIEW
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENTS

12.8 LUCID GROUP LIMITED

12.8.1 COMPANY OVERVIEW
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENTS

13 RELATED REPORTS

Customization with Discount Available On This Report at https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-smart-pills-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.